PRNB

Principia Biopharma (PRNB)

Principia Biopharma Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PRNB

1 2 3 4 5 6 7 8 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2021/02/17	05 : 14	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:PRNB	Principia Biopharma Inc
2020/11/24	22 : 00	GlobeNewswire Inc.	Patient Enrollment Concluded Early in PEGASUS Phase 3 Pemphigus Trial for Rilzabrutinib	NASDAQ:PRNB	Principia Biopharma Inc
2020/10/08	20 : 01	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:PRNB	Principia Biopharma Inc
2020/10/01	19 : 06	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:PRNB	Principia Biopharma Inc
2020/09/29	06 : 28	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PRNB	Principia Biopharma Inc
2020/09/29	06 : 22	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PRNB	Principia Biopharma Inc
2020/09/29	06 : 17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PRNB	Principia Biopharma Inc
2020/09/29	06 : 08	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PRNB	Principia Biopharma Inc
2020/09/28	22 : 20	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:PRNB	Principia Biopharma Inc
2020/09/28	22 : 18	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:PRNB	Principia Biopharma Inc
2020/09/28	22 : 16	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:PRNB	Principia Biopharma Inc
2020/09/28	22 : 12	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:PRNB	Principia Biopharma Inc
2020/09/28	21 : 49	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...	NASDAQ:PRNB	Principia Biopharma Inc
2020/09/28	21 : 43	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PRNB	Principia Biopharma Inc
2020/09/28	19 : 35	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:PRNB	Principia Biopharma Inc
2020/09/28	19 : 31	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:PRNB	Principia Biopharma Inc
2020/09/22	19 : 44	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:PRNB	Principia Biopharma Inc
2020/09/22	19 : 32	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:PRNB	Principia Biopharma Inc
2020/09/17	21 : 01	GlobeNewswire Inc.	Principia Announces First Patient Dosed in Phase 2A Trial of Rilzabrutinib in IgG4-Related Disease	NASDAQ:PRNB	Principia Biopharma Inc
2020/09/15	05 : 34	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:PRNB	Principia Biopharma Inc
2020/09/10	23 : 04	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:PRNB	Principia Biopharma Inc
2020/09/10	21 : 00	GlobeNewswire Inc.	Neoleukin Therapeutics Announces Appointment of Martin Babler to Board of Directors	NASDAQ:PRNB	Principia Biopharma Inc
2020/08/28	14 : 44	Dow Jones News	Sanofi to Launch Tender Offer for Principia Acquisition	NASDAQ:PRNB	Principia Biopharma Inc
2020/08/26	01 : 33	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:PRNB	Principia Biopharma Inc
2020/08/21	19 : 01	Edgar (US Regulatory)	Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)	NASDAQ:PRNB	Principia Biopharma Inc
2020/08/21	05 : 31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PRNB	Principia Biopharma Inc
2020/08/21	05 : 20	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:PRNB	Principia Biopharma Inc
2020/08/20	02 : 50	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:PRNB	Principia Biopharma Inc
2020/08/18	19 : 01	Edgar (US Regulatory)	Written Communication Relating to an Issuer or Third Party (sc To-c)	NASDAQ:PRNB	Principia Biopharma Inc
2020/08/18	16 : 02	Dow Jones News	Sanofi Buys MS-Drug Development Partner -- WSJ	NASDAQ:PRNB	Principia Biopharma Inc